A Multi-Centre, Double-Blind, Randomised, Parallel Group, Escitalopram Controlled Phase III-B Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR TM) as Monotherapy in the Treatment of Adult Patients With Agitated Major Depressive Disorder.
Phase of Trial: Phase III
Latest Information Update: 28 Jan 2014
At a glance
- Drugs Quetiapine (Primary) ; Escitalopram
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms Quietude
- 28 Jan 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 03 Jun 2011 New trial record